Literature DB >> 34191084

Update of pediatric soft tissue tumors with review of conventional MRI appearance-part 1: tumor-like lesions, adipocytic tumors, fibroblastic and myofibroblastic tumors, and perivascular tumors.

Jack Porrino1, Khalid Al-Dasuqi2, Lina Irshaid3, Annie Wang2, Kimia Kani4, Andrew Haims2, Ezekiel Maloney5.   

Abstract

There are numerous soft tissue tumors and tumor-like conditions in the pediatric population. Magnetic resonance imaging is the most useful modality for imaging these lesions. Although certain soft tissue lesions exhibit magnetic resonance features characteristic of a specific diagnosis, most lesions are indeterminate, and a biopsy is necessary for diagnosis. We provide a detailed update of soft tissue tumors and tumor-like conditions that occur in the pediatric population, emphasizing each lesion's conventional magnetic resonance imaging appearance, using the recently released 5th edition of the World Health Organization Classification of Soft Tissue and Bone Tumors as a guide. In part one of this review, pediatric tumor-like lesions, adipocytic tumors, fibroblastic and myofibroblastic tumors, and perivascular tumors are discussed. In part two, vascular lesions, fibrohistiocytic tumors, muscle tumors, peripheral nerve sheath tumors, tumors of uncertain differentiation, and undifferentiated small round cell sarcomas are reviewed. Per the convention of the WHO, these lesions involve the connective, subcutaneous, and other non-parenchymatous-organ soft tissues, as well as the peripheral and autonomic nervous system.
© 2021. ISS.

Entities:  

Keywords:  Pediatric; Sarcoma; Soft tissue mass; Tumor; Vascular malformation

Mesh:

Year:  2021        PMID: 34191084     DOI: 10.1007/s00256-021-03836-2

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  128 in total

Review 1.  Magnetic resonance imaging of soft-tissue tumors in children.

Authors:  Soroosh Mahboubi
Journal:  Top Magn Reson Imaging       Date:  2002-08

Review 2.  Pediatric soft-tissue tumors.

Authors:  Kamran Aflatoon; Albert J Aboulafia; Edward F McCarthy; Frank J Frassica; Alan M Levine
Journal:  J Am Acad Orthop Surg       Date:  2003 Sep-Oct       Impact factor: 3.020

Review 3.  Pediatric soft tissue sarcomas.

Authors:  Rebecca Stein-Wexler
Journal:  Semin Ultrasound CT MR       Date:  2011-10       Impact factor: 1.875

4.  Non-neoplastic conditions presenting as soft-tissue tumours.

Authors:  N Crundwell; P O'Donnell; A Saifuddin
Journal:  Clin Radiol       Date:  2007-01       Impact factor: 2.350

5.  Detection of soft-tissue abscess: Comparison of diffusion-weighted imaging to contrast-enhanced MRI.

Authors:  Chang Woo Chun; Joon-Yong Jung; Jun Seung Baik; Won-Hee Jee; Sun Ki Kim; Seung Han Shin
Journal:  J Magn Reson Imaging       Date:  2017-04-22       Impact factor: 4.813

Review 6.  De Novo Assessment of Pediatric Musculoskeletal Soft Tissue Tumors: Beyond Anatomic Imaging.

Authors:  Shivani Ahlawat; Laura M Fayad
Journal:  Pediatrics       Date:  2015-07       Impact factor: 7.124

Review 7.  The magnetic resonance imaging of musculoskeletal hemorrhage.

Authors:  C H Bush
Journal:  Skeletal Radiol       Date:  2000-01       Impact factor: 2.199

Review 8.  Fat-containing soft-tissue masses in children.

Authors:  Elizabeth F Sheybani; Eric P Eutsler; Oscar M Navarro
Journal:  Pediatr Radiol       Date:  2016-11-19

Review 9.  The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities.

Authors:  Joon Hyuk Choi; Jae Y Ro
Journal:  Adv Anat Pathol       Date:  2021-01       Impact factor: 3.875

10.  The "penumbra sign" on T1-weighted MRI for differentiating musculoskeletal infection from tumour.

Authors:  B McGuinness; N Wilson; A J Doyle
Journal:  Skeletal Radiol       Date:  2007-03-06       Impact factor: 2.199

View more
  1 in total

Review 1.  NIR-I Dye-Based Probe: A New Window for Bimodal Tumor Theranostics.

Authors:  Fan Zheng; Xueyan Huang; Jipeng Ding; Anyao Bi; Shifen Wang; Fei Chen; Wenbin Zeng
Journal:  Front Chem       Date:  2022-03-23       Impact factor: 5.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.